Over the past decade, there has been accumulating experimental evidence that cell transplantation could be a new, effective approach for repairing damaged myocardium. Nevertheless, most of these preclinical and clinical studies on cell therapy have been performed in ischemic cardiomyopathy. In this paper, the authors focused on the available evidence in the treatment of non-ischemic dilated cardiomyopathy with different types of stem cells.
Dilated cardiomyopathy, therapy; Stem cells; Tissue therapy; Heart failure, congestive, therapy
